[Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].
作者信息
Menéndez Torre Edelmiro, Lafita Tejedor Francisco Javier, Artola Menéndez Sara, Millán Núñez-Cortés Jesús, Alonso García Angeles, Puig Domingo Manuel, García Solans José Ramón, Alvarez Guisasola Fernando, García Alegría Javier, Mediavilla Bravo Javier, Miranda Fernández-Santos Carlos, Romero González Ramón
机构信息
Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes, Spain.
出版信息
Aten Primaria. 2011 Apr;43(4):202.e1-9. doi: 10.1016/j.aprim.2010.07.012. Epub 2011 Mar 5.
Abstract
摘要
相似文献
1
[Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].[2型糖尿病高血糖药物治疗的建议]
Aten Primaria. 2011 Apr;43(4):202.e1-9. doi: 10.1016/j.aprim.2010.07.012. Epub 2011 Mar 5.
2
[Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].[2型糖尿病高血糖药物治疗的建议]
Rev Clin Esp. 2011 Mar;211(3):147-55. doi: 10.1016/j.rce.2010.11.006. Epub 2011 Mar 3.
3
[Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].[2型糖尿病高血糖的药物治疗建议]
Endocrinol Nutr. 2011 Mar;58(3):112-20. doi: 10.1016/j.endonu.2010.07.005. Epub 2011 Feb 26.
4
Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document.2型糖尿病高血糖药物治疗的建议。共识文件。
Nefrologia. 2011;31(1):17-26. doi: 10.3265/Nefrologia.pre2010.Nov.10715.
5
[Treatment guidelines for hyperglycaemia in type 2 diabetes patients with stable chronic heart failure or ischemic cardiomyopathy without heart failure].2型糖尿病合并稳定型慢性心力衰竭或无心力衰竭的缺血性心肌病患者高血糖的治疗指南
Med Clin (Barc). 2010 May 8;134(13):596-9. doi: 10.1016/j.medcli.2010.01.028. Epub 2010 Mar 19.
6
Role of metformin in type II diabetes.二甲双胍在2型糖尿病中的作用。
Cleve Clin J Med. 1995 Sep-Oct;62(5):278-9. doi: 10.3949/ccjm.62.5.278.
7
Hyperglycaemia in inpatients with type 2 diabetes mellitus.2型糖尿病住院患者的高血糖症
Br J Hosp Med (Lond). 2012 Aug;73(8):C124-8. doi: 10.12968/hmed.2012.73.sup8.c124.
8
Managing hyperglycaemia.控制高血糖
Br J Gen Pract. 2008 Oct;58(555):729; authore reply 729-30. doi: 10.3399/bjgp08X342408.
9
Diabetes: insulin plus metformin for T2DM--are there benefits?糖尿病：2型糖尿病使用胰岛素加二甲双胍——有什么益处吗？
Nat Rev Endocrinol. 2012 Jun 26;8(8):449-50. doi: 10.1038/nrendo.2012.106.
10
Metformin added to insulin therapy in poorly controlled type 2 diabetes.在控制不佳的2型糖尿病患者中，二甲双胍联合胰岛素治疗。
Diabetes Care. 1999 May;22(5):854. doi: 10.2337/diacare.22.5.854b.
引用本文的文献
1
Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis.伊朗 2 型糖尿病患者的个体化血糖控制：多中心数据分析。
Iran J Med Sci. 2023 May;48(3):286-291. doi: 10.30476/ijms.2022.92805.2409.
2
[Trends in the level of control of patients with type 2 diabetes from 2010 to 2015].[2010年至2015年2型糖尿病患者的控制水平趋势]
Aten Primaria. 2018 Oct;50(8):459-466. doi: 10.1016/j.aprim.2017.04.002. Epub 2017 Aug 21.
3
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain.利拉鲁肽与利司那肽对比：西班牙2型糖尿病治疗中GLP-1受体激动剂疗法的长期成本效益
Diabetes Ther. 2017 Apr;8(2):401-415. doi: 10.1007/s13300-017-0239-6. Epub 2017 Feb 21.
4
Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.在西班牙，使初级保健的2型糖尿病患者达到个体化血糖目标。
BMC Endocr Disord. 2016 Feb 17;16:10. doi: 10.1186/s12902-016-0090-1.
5
[Prospective observational study of insulin detemir in patients with poorly controlled type 2 diabetes mellitus initiating insulin therapy for the first time (SOLVE Study)].德谷胰岛素用于首次起始胰岛素治疗的2型糖尿病控制不佳患者的前瞻性观察性研究（SOLVE研究）
Aten Primaria. 2016 Feb;48(2):95-101. doi: 10.1016/j.aprim.2015.02.010. Epub 2015 Jun 6.
6
[Cost-effectiveness analysis of dapagliflozin compared to DPP4 inhibitors and other oral antidiabetic drugs in the treatment of type-2 diabetes mellitus in Spain].[在西班牙，达格列净与二肽基肽酶-4抑制剂及其他口服抗糖尿病药物治疗2型糖尿病的成本效益分析]
Aten Primaria. 2015 Oct;47(8):505-13. doi: 10.1016/j.aprim.2014.11.002. Epub 2014 Dec 30.
本文引用的文献
1
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.加拿大糖尿病协会2013年加拿大糖尿病预防与管理临床实践指南。引言。
Can J Diabetes. 2013 Apr;37 Suppl 1:S1-3. doi: 10.1016/j.jcjd.2013.01.009. Epub 2013 Mar 26.
2
Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.在接受罗格列酮或吡格列酮治疗的老年医疗保险患者中，急性心肌梗死、中风、心力衰竭和死亡的风险。
JAMA. 2010 Jul 28;304(4):411-8. doi: 10.1001/jama.2010.920. Epub 2010 Jun 28.
3
A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.一项 24 周、随机、以目标为导向的临床试验，比较了每日一次甘精胰岛素起始治疗与每日两次地特胰岛素起始治疗在口服降糖药物控制不佳的 2 型糖尿病患者中的疗效。
Diabetes Care. 2010 Jun;33(6):1176-8. doi: 10.2337/dc09-2294. Epub 2010 Mar 3.
4
A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.一项关于每日一次使用利拉鲁肽（一种人胰高血糖素样肽 1 类似物）治疗 2 型糖尿病的疗效和安全性数据的综述。
Clin Ther. 2009 Nov;31(11):2472-88. doi: 10.1016/j.clinthera.2009.11.034.
5
Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17).二甲双胍-磺脲类-吡格列酮三联疗法在 PROactive（PROactive 17）中的长期血糖控制。
Diabet Med. 2009 Oct;26(10):1033-9. doi: 10.1111/j.1464-5491.2009.02816.x.
6
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.美国临床内分泌医师协会/美国内分泌学会关于 2 型糖尿病的共识声明：血糖控制的算法。
Endocr Pract. 2009 Sep-Oct;15(6):540-59. doi: 10.4158/EP.15.6.540.
7
Three-year efficacy of complex insulin regimens in type 2 diabetes.复杂胰岛素治疗方案对2型糖尿病的三年疗效
N Engl J Med. 2009 Oct 29;361(18):1736-47. doi: 10.1056/NEJMoa0905479. Epub 2009 Oct 22.
8
Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin--diabetes control and potential adverse events.用西他列汀、维格列汀或沙格列汀治疗2型糖尿病患者的临床结果——血糖控制及潜在不良事件
Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):487-98. doi: 10.1016/j.beem.2009.03.003.
9
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes.沙格列汀单药治疗对初治2型糖尿病患者的疗效。
Curr Med Res Opin. 2009 Oct;25(10):2401-11. doi: 10.1185/03007990903178735.
10
Earlier triple therapy with pioglitazone in patients with type 2 diabetes. 早期三联疗法治疗 2 型糖尿病患者的吡格列酮。
Diabetes Obes Metab. 2009 Sep;11(9):844-54. doi: 10.1111/j.1463-1326.2009.01055.x. Epub 2009 Jul 13.
Zotero 插件